Health In Tech (NASDAQ:HIT) Announces Earnings Results, Misses Expectations By $0.03 EPS

Health In Tech (NASDAQ:HIT) issued its quarterly earnings results on Thursday. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.03), Zacks reports.

Here are the key takeaways from Health In Tech’s conference call:

• Health In Tech appointed Sanjay Shrestha CEO, with founder Tim Johnson moving to Executive Chairman. Management says the split is intended to pair continued technology development with sharper focus on commercial execution, operational discipline, and scaling the business.
• The company cut its 2026 revenue outlook to approximately $30 million; third-quarter revenue fell to $6.6 million from $8.5 million a year earlier. The quarter also included a $5.3 million credit-loss provision, adjusted EBITDA was negative $3.9 million, and gross margin declined to 46.5%.
• Management cited $156.4 million in pipeline revenue for policies in quoting or binding stages as of October 30, but emphasized this is not contracted revenue and depends on successful placement. The company estimates a 3%–7% conversion rate and says improving conversion through closer partner coordination is its top near-term priority.
• Commercialization timelines for new initiatives remain conditional: the Three-Year Rate Stabilization Program’s insurance coverage is in place, but its capital-markets financing is still being finalized; HitRix’s MVP is targeted for Q1 2027 and HITChain’s for the second half of 2027. Management described these products as potential growth drivers but acknowledged that commercialization has taken longer than expected.
• Operating cash use improved sequentially to $1.0 million in Q3 from $3.3 million in Q1, and cash stood at $10.1 million at quarter-end, up from $7.7 million at year-end 2025. Management attributed the improvement partly to collections and working-capital progress, while noting that continued cash-flow improvement will depend on execution.

Health In Tech Trading Down 7.5%

Shares of NASDAQ:HIT traded down $0.04 during mid-day trading on Friday, reaching $0.49. The stock had a trading volume of 56,332 shares, compared to its average volume of 217,386. The firm has a market cap of $32.44 million, a PE ratio of -7.07 and a beta of 3.02. The firm has a 50 day simple moving average of $0.73 and a two-hundred day simple moving average of $1.11. Health In Tech has a twelve month low of $0.45 and a twelve month high of $2.10.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Maxim Group dropped their price target on Health In Tech from $4.00 to $3.00 and set a “buy” rating on the stock in a research report on Friday, August 14th. Weiss Ratings reissued a “sell (d)” rating on shares of Health In Tech in a research note on Friday, September 25th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $3.50.

About Health In Tech

Health In Tech, Inc. is a U.S.-based insurance technology company that provides a digital platform for the self-funded health benefits market. Its technology is designed to connect employers, insurance brokers, third-party administrators and stop-loss carriers through a streamlined process for evaluating and administering health benefit plans. The company’s platform supports functions including plan quoting, comparison and enrollment, with the goal of simplifying interactions among participants in the employer-sponsored health insurance ecosystem.